Timothy McNicoll, MD
Hospitalist · Stamford, CTNPI 1790750115
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,702 and has fallen 96.3% since, to $62 in 2025. Among hospitalist clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 131 payments — averaging $16.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$434
- GSK$215
- AstraZeneca$196
- AbbVie$128
- Merck$125
- Novartis$97
- plus $946 from 22 others
What the payments were for
- Food & beverage$2,141100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 18 | $434 |
| GSK | 27 | $215 |
| AstraZeneca | 11 | $196 |
| AbbVie | 7 | $128 |
| Merck | 8 | $125 |
| Novartis | 6 | $97 |
| Novo Nordisk | 5 | $88 |
| Johnson & Johnson | 5 | $82 |
| Teva Pharmaceuticals USA, Inc. | 4 | $82 |
| Stryker | 1 | $74 |
| Boston Scientific | 3 | $69 |
| Pfizer | 5 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $60 |
| Vertiflex, Inc. | 3 | $55 |
| Astellas Pharma US Inc | 3 | $54 |
| Boehringer Ingelheim | 3 | $49 |
| Amarin Pharma, Inc. | 2 | $46 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $45 |
| Genentech USA, Inc. | 2 | $25 |
| Bristol Myers Squibb | 1 | $22 |
| Ironshore Pharmaceuticals Inc. | 1 | $22 |
| Therapeuticsmd, Inc. | 1 | $21 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
| Axonics, Inc. | 1 | $13 |
| Phadia US Inc. | 1 | $13 |
How this compares
$2,141 in reported general payments places this provider in the 95th percentile of 349 hospitalist providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 31 | $9,665 |
| Nifedipine ErNifedipine | 14 | $285 |
| Losartan Potassium | 33 | $283 |
| ClopidogrelClopidogrel Bisulfate | 13 | $233 |
| Levothyroxine Sodium | 41 | $213 |
| Pantoprazole Sodium | 27 | $178 |
| Atorvastatin Calcium | 29 | $168 |
| Bupropion XlBupropion Hcl | 12 | $142 |
| Hydralazine Hcl | 16 | $136 |
| Furosemide | 34 | $130 |
| Escitalopram Oxalate | 17 | $129 |
| Methylprednisolone | 15 | $97 |
| Pregabalin | 12 | $94 |
| Tamsulosin Hcl | 12 | $72 |
| Amlodipine Besylate | 24 | $65 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $82 | $9,66531 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 349 hospitalist providers in Connecticut.
Other hospitalist in Stamford
- Shawn SamuelStamford$6K
- Saikou SaidyStamford$755
- Lin CorsonStamford$438
- Angela CandelariaFairfield$9K
- Ashanee ThompsonBridgeport$6K
- Roy KellermanHartford$5K
- Muhammad FarooqHartford$5K
- Joseph FuscoHartford$4K
- Edgar NautHartford$4K
- Gagan SinghHartford$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.